dimethyl itaconate has been researched along with Chronic Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, Y; Yin, HQ | 1 |
1 other study(ies) available for dimethyl itaconate and Chronic Lung Injury
| Article | Year |
|---|---|
Dimethyl itaconate inhibits LPS-induced inflammatory release and apoptosis in alveolar type II epithelial and bronchial epithelial cells by activating pulmonary surfactant proteins A and D.
Topics: Apoptosis; Epithelial Cells; Humans; Lipopolysaccharides; Lung Injury; Molecular Docking Simulation; Pulmonary Surfactant-Associated Protein A; Pulmonary Surfactant-Associated Protein D; Pulmonary Surfactants; Sirtuin 1; Surface-Active Agents | 2022 |